We finally identify the entire CD137+ T cell population, and in particular the most functionally active CD137+PD1+ T cell subset as two favorable prognostic factors of survival in the entire population of NSCLC patients. This evidence concerns the gene TNFRSF9 and non-small cell lung carcinoma.